{
    "id": "New-v26-7a3b9c2d-4e5f-401a-8b2c-9d3e5f7a9b1c",
    "type": "selectN",
    "stem": "The patient is exhibiting manifestations of hyperkalemia. Based on the EHR, which interventions are MOST appropriate to implement *immediately*?",
    "scoring": {
        "method": "polytomous",
        "maxPoints": 5
    },
    "itemContext": {
        "patient": {
            "name": "Jameson Tyrell",
            "age": 72,
            "gender": "Male",
            "iso": "Medical Surgical Unit",
            "allergies": [
                "Penicillin"
            ],
            "isolation": "standard"
        },
        "sbar": "15:00 Report:\nMr. Tyrell is a 72-year-old male admitted at 08:00 today for acute kidney injury (AKI) secondary to dehydration. His history includes hypertension and benign prostatic hyperplasia (BPH). Urine output has been minimal since admission, less than 30 mL/hr. He's on 2L O2 via nasal cannula. At 14:30, he reported muscle weakness and nausea; peaked T waves were noted on telemetry. At 14:45, the physician was notified, and new orders are pending implementation. Current meds: Lisinopril 20mg daily, Tamsulosin 0.4mg daily. Vitals at 14:50: BP 160/90, HR 98, RR 24, SpO2 94%, Temp 37.2째C. He is alert and oriented, reporting pain 2/10. The physician is en route for evaluation.",
        "tabs": [
            {
                "id": "labs",
                "title": "Laboratory Results",
                "content": "|\tLab Name\t|\tValue\t|\tReference Range\t|\n|-----------------------|----------------------|---------------------------|\n|\tSodium\t|\t140 mEq/L\t|\t135-145 mEq/L\t|\n|\tPotassium\t|\t6.8 mEq/L\t|\t3.5-5.0 mEq/L\t|\n|\tChloride\t|\t102 mEq/L\t|\t98-106 mEq/L\t|\n|\tBUN\t|\t55 mg/dL\t|\t10-20 mg/dL\t|\n|\tCreatinine\t|\t3.2 mg/dL\t|\t0.6-1.2 mg/dL\t|\n|\tGlucose\t|\t110 mg/dL\t|\t70-110 mg/dL\t|\n|\tCalcium\t|\t8.5 mg/dL\t|\t8.5-10.5 mg/dL\t|\n|\tMagnesium\t|\t2.0 mg/dL\t|\t1.5-2.5 mg/dL\t|\n|\tpH\t|\t7.30\t|\t7.35-7.45\t|\n|\tHCO3\t|\t22 mEq/L\t|\t22-26 mEq/L\t|"
            },
            {
                "id": "vitals",
                "title": "Vital Signs",
                "content": "|\tTime\t|\tBP\t|\tHR\t|\tRR\t|\tSpO2\t|\tTemp\t|\n|-----------------------|----------------------|----------------------|----------------------|---------------------------|----------------------|\n|\t14:50\t|\t160/90\t|\t98\t|\t24\t|\t94%\t|\t37.2째C\t|\n|\t14:00\t|\t150/85\t|\t92\t|\t22\t|\t95%\t|\t37.0째C\t|\n|\t13:00\t|\t145/80\t|\t88\t|\t20\t|\t96%\t|\t36.8째C\t|"
            },
            {
                "id": "mar",
                "title": "Medication Administration Record",
                "content": "|\tMedication\t|\tDose\t|\tRoute\t|\tFrequency\t|\tLast Administered\t|\n|-----------------------|----------------------|----------------------|----------------------|---------------------------|\n|\tLisinopril\t|\t20 mg\t|\tPO\t|\tDaily\t|\t08:00\t|\n|\tTamsulosin\t|\t0.4 mg\t|\tPO\t|\tDaily\t|\t08:00\t|\n|\tSodium Polystyrene Sulfonate\t|\t15 g\t|\tPO\t|\tSTAT\t|\tScheduled\t|\n|\tCalcium Gluconate\t|\t1 g\t|\tIV\t|\tSTAT\t|\tScheduled\t|\n|\tRegular Insulin\t|\t10 units\t|\tIV\t|\tSTAT\t|\tScheduled\t|\n|\tD50W\t|\t50 mL\t|\tIV\t|\tSTAT\t|\tScheduled\t|"
            },
            {
                "id": "radiology",
                "title": "Radiology Reports",
                "content": "No radiology reports available."
            }
        ]
    },
    "pedagogy": {
        "bloomLevel": "apply",
        "cjmmStep": "analyzeCues",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 5,
        "topicTags": [
            "Renal: AKI vs CKD & Electrolyte Emergencies"
        ]
    },
    "rationale": {
        "correct": "Administering calcium gluconate stabilizes the myocardial cell membrane, reducing dysrhythmia risk from hyperkalemia. Insulin with D50W shifts potassium from extracellular fluid into cells, temporarily lowering serum potassium. Sodium polystyrene sulfonate (Kayexalate) binds potassium in the GI tract for fecal excretion, reducing serum potassium. Telemetry monitoring allows early detection of life-threatening dysrhythmias. Assessing muscle strength monitors treatment effectiveness and identifies hyperkalemia complications.",
        "incorrect": "Furosemide may be ineffective in AKI with minimal urine output. While it can excrete potassium, its effectiveness is limited by impaired renal function. Lisinopril can worsen hyperkalemia by inhibiting aldosterone, which promotes potassium excretion; holding it is more appropriate. Increasing oxygen flow is unnecessary with SpO2 at 94%. While hypertensive, the priority is the electrolyte imbalance.",
        "clinicalPearls": [
            "Hyperkalemia can cause life-threatening cardiac dysrhythmias; early recognition is crucial.",
            "Calcium gluconate doesn't lower potassium; it protects the heart from hyperkalemia's effects.",
            "Insulin/D50W temporarily shifts potassium into cells. Kayexalate offers a more permanent solution but takes longer."
        ],
        "questionTrap": {
            "trap": "The trap is focusing on hypertension and overlooking the immediate hyperkalemia threat. Students might address hypertension first, missing the priority intervention.",
            "howToOvercome": "Focus on the stem's primary problem (hyperkalemia) and prioritize interventions addressing that imbalance. Remember ABCs but consider electrolyte emergencies."
        },
        "mnemonic": {
            "title": "K-IND",
            "expansion": "K - Kayexalate (Sodium Polystyrene Sulfonate), I - Insulin & Dextrose, N - NaHCO3 (Sodium Bicarbonate - less common), D - Diuretics (Furosemide, if kidneys function)"
        }
    },
    "options": [
        {
            "key": "A",
            "label": "Administer calcium gluconate 1 g IV.",
            "correct": true
        },
        {
            "key": "B",
            "label": "Administer furosemide 40 mg IV.",
            "correct": false
        },
        {
            "key": "C",
            "label": "Administer regular insulin 10 units IV with D50W 50 mL IV.",
            "correct": true
        },
        {
            "key": "D",
            "label": "Administer sodium polystyrene sulfonate 15 g PO.",
            "correct": true
        },
        {
            "key": "E",
            "label": "Hold the next dose of lisinopril.",
            "correct": false
        },
        {
            "key": "F",
            "label": "Increase oxygen flow rate to 4L via nasal cannula.",
            "correct": false
        },
        {
            "key": "G",
            "label": "Initiate continuous telemetry monitoring.",
            "correct": true
        },
        {
            "key": "H",
            "label": "Assess the patient's muscle strength.",
            "correct": true
        }
    ],
    "sentinelStatus": "deep_healed_v2026"
}